LENZ Therapeutics (LENZ) Shares Issued (2021 - 2026)
LENZ Therapeutics (LENZ) reported Shares Issued of $14000.0 for Q1 2026, down 68.18% year-over-year from $44000.0 in Q1 2025, and down 60.0% on a QoQ basis from $35000.0 in Q4 2025.
LENZ Therapeutics (LENZ) has 6 years of Shares Issued data on file, last reported at $14000.0 in Q1 2026.
- Quarterly Shares Issued fell 68.18% year-over-year to $14000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.7 million (up 154.25% YoY) and the FY2025 annual result came in at $873000.0, down 78.38% from the prior year.
- Shares Issued retreated to $14000.0 in Q1 2026 per LENZ's latest filing, from $35000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $53.4 million in Q1 2024 and bottomed at -$49.5 million in Q2 2024.
- The 5-year median for Shares Issued is $97500.0 (2024), against an average of $2.2 million.
- Peak annual rise in Shares Issued reached 26199.01% in 2024, while the deepest fall reached 24305.91% in 2024.
- Tracing LENZ's Shares Issued over 5 years: stood at $242000.0 in 2022, then sank by 183.88% to -$203000.0 in 2023, then surged by 167.98% to $138000.0 in 2024, then tumbled by 74.64% to $35000.0 in 2025, then tumbled by 60.0% to $14000.0 in 2026.
- Per Business Quant, the three latest LENZ Shares Issued figures stand at $14000.0 (Q1 2026), $35000.0 (Q4 2025), and $598000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | LENZ Therapeutics | 235.77 Mn | 235.77 Mn | 825,000.00 | 14,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Dec 31, 2025 | 35,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Sep 30, 2025 | 598,000.00 |
| Jun 30, 2025 | 26.10 Mn |
| Jun 30, 2025 | 26.10 Mn |
| Mar 31, 2025 | 44,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | -49.54 Mn |
| Jun 30, 2024 | -49.54 Mn |
| Mar 31, 2024 | 53.39 Mn |
| Mar 31, 2024 | 53.39 Mn |
| Dec 31, 2023 | -203,000.00 |
| Dec 31, 2023 | -203,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Sep 30, 2023 | 203,000.00 |
| Jun 30, 2023 | -203,000.00 |
| Jun 30, 2023 | -203,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Mar 31, 2023 | 203,000.00 |
| Dec 31, 2022 | 242,000.00 |
| Dec 31, 2022 | 242,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | -219.43 Mn |
| Sep 30, 2021 | -219.43 Mn |
| Jun 30, 2021 | 219.19 Mn |
| Jun 30, 2021 | 219.19 Mn |
| Mar 31, 2021 | 268,000.00 |
| Mar 31, 2021 | 268,000.00 |